A simple scrape or sore might not cause alarm for most people. But for diabetic patients, an untreated scratch can turn into an open wound that could potentially lead to a limb amputation or even death.
With Regeneron Pharmaceuticals' Eylea having exited its imperious growth phase, the company is looking at opportunities to expand revenue for the franchise before competition intensifies.